Insights Services

1. What other indications could my drug be effective for?
2. Which patients across the indications are likely to respond to therapy?

Which cellular microenvironments predict drug response in my patient cohort?

1. Which biological features correlate with response to therapy?
2. What biological features correlate with refractory disease?

Where are the TAMs in the tumor microenvironment?

Are exhausted and regulatory T cells present in my samples?

Are activated lymphocytes present in my samples?

Which samples are immunologically infiltrated or excluded?

What spatial features define the tumor microenvironment in my samples?